Migraine is a disabling neurological disorder, diagnosis of which is based on clinical criteria.
A shortcoming of these criteria is that they do not fully capture the heterogeneity of migraine …

Objective The focus of this review is to review potential diagnostic and therapeutic
biomarkers associated with migraine. Background Migraine headache is a common disease …

Migraine is a common, disabling, and undertreated episodic brain disorder that is more
common in women than in men. Unbiased genome-wide association studies have identified …

The understanding of migraine pathophysiology is advancing rapidly. Improved
characterisation and diagnosis of its clinical features have led to the view of migraine as a …

Background Migraine is a complex neurovascular disorder with a strong genetic component.
There are rare monogenic forms of migraine, as well as more common polygenic forms; …

Objectives Population prevalence studies of migraine report prevalence rates of between
2.6 and 21.7%, with an average of~ 12%. However, migraine prevalence among …

Genetics of migraine has recently undergone a major shift, moving in the space of a few
years from having only a few known genes for rare Mendelian forms to 47 known common …

Migraine affects over a billion individuals worldwide but its genetic underpinning remains
largely unknown. Here, we performed a genome-wide association study of 102,084 …

Migraine is a debilitating neurological disorder affecting around one in seven people
worldwide, but its molecular mechanisms remain poorly understood. There is some debate …

Migraine is a common neurological disorder which affects 15–20% of the population; it has a
high socioeconomic impact through treatment and loss of productivity. Current forms of …